# SOUNDTRACK-B (NCT06526793)

> Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06526793
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: AstraZeneca
- Conditions: B-cell Non-Hodgkin Lymphoma; Follicular Lymphoma (FL); Large B-Cell Lymphoma (LBCL)
- Interventions: Surovatamig
- Enrollment: 270
- Primary outcome: Overall response rate (ORR) (central review)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- YouTube: 5
- Podcasts: 2
- X threads: 2

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=soundtrack-b-nct06526793

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06526793", "email": "<work email>"}; the inbox owner confirms by the emailed link.